| Literature DB >> 35251473 |
Wanting Hou1,2, Guobin Liu2,3, Xuelian Ren2, Xianming Liu4, Lei He4, He Huang1,2,3,5.
Abstract
Lysine β-hydroxybutyrylation (Kbhb) is a newly identified protein posttranslational modification (PTM) derived from β-hydroxybutyrate (BHB), a product of ketone body metabolism in liver. BHB could serve as an energy source and play a role in the suppression of oxidative stress. The plasma concentration of BHB could increase up to 20 mM during starvation and in pathological conditions. Despite the progress, how the cells derived from extrahepatic tissues respond to elevated environmental BHB remains largely unknown. Given that BHB can significantly drive Kbhb, we characterized the BHB-induced lysine β-hydroxybutyrylome and acetylome by quantitative proteomics. A total of 840 unique Kbhb sites on 429 proteins were identified, with 42 sites on 39 proteins increased by more than 50% in response to BHB. The results showed that the upregulated Kbhb induced by BHB was involved in aminoacyl-tRNA biosynthesis, 2-oxocarboxylic acid metabolism, citrate cycle, glycolysis/gluconeogenesis, and pyruvate metabolism pathways. Moreover, some BHB-induced Kbhb substrates were significantly involved in diseases such as cancer. Taken together, we investigate the dynamics of lysine β-hydroxybutyrylome and acetylome induced by environmental BHB, which reveals the roles of Kbhb in regulating various biological processes and expands the biological functions of BHB.Entities:
Mesh:
Substances:
Year: 2022 PMID: 35251473 PMCID: PMC8894020 DOI: 10.1155/2022/4592170
Source DB: PubMed Journal: Oxid Med Cell Longev ISSN: 1942-0994 Impact factor: 6.543
Figure 1Systematic profiling of lysine β-hydroxybutylome and acetylome. (a) Illustration of enzymatic reaction for acetyl-lysine and β-hydroxybutyryl-lysine. (b) Schematic representation of experimental workflow for the identification and quantification of Kbhb and Kac in MEF cells. (c) Pie chart shows experimental reproducibility of three biological replicates.
Figure 2Characterization of Kbhb proteome. (a) Venn diagram shows cellular compartment distribution of Kbhb proteins. (b) Distribution of the Kbhb sites number per protein. (c) The bar graph shows the proteins containing more than 6 Kbhb sites. (d) Consensus sequence logo shows a representative sequence for BHB-induced Kbhb sites.
Figure 3Quantitative analysis of BHB-induced Kbhb and Kac proteome. (a) BHB enhances Kbhb of proteins in MEF cells. Histone Kbhb and Kac levels were analyzed in control and BHB treated MEF cells by immuno-blotting with the indicated antibodies. (b) The scatter plot shows quantification of Kbhb and Kac sites. (c) Venn diagram shows no crossover between the upregulated Kbhb and Kac sites. (d) The KEGG pathway of Kbhb and Kac proteome induced by BHB.
Figure 4The KEGG and GO biological process analysis. (a) The KEGG pathway of Kac proteome. (b) The GO annotation of Kac proteome. (c) The KEGG pathway of Kbhb proteome. (d) The GO annotation of Kbhb proteome. All the Kbhb and Kac sites were divided into four groups on average according to their dynamics in response to BHB treatment (in ascending order of the treated/control ratio).
Figure 5Interaction network of Kbhb and Kac proteome. The blue and red circle represented the proteins with upregulated Kbhb and Kac levels, respectively.
Kbhb sites on key residues involving substrate/cofactor binding, protein interaction, and cancer biomarkers.
| Protein | Site | Feature |
|---|---|---|
| Fasn | 673 | Acyl and malonyl transferases |
| Uba52 | 6 | Lung cancer biomarker |
| Tsn | 187 | Leucine-zipper region |
| Pdlim1 | 254 | Binding with zinc at 258 and 261 sites |
| Pgam5 | 140 | Phosphatase activity of serine/threonine residues |
| Gstm1 | 136 | Breast cancer biomarker |
| Aco2 | 50 | Catalyzes citrate to isocitrate |
| Eno1 | 256 | Participates in glycolysis process |
Figure 6Three-dimensional structure of Fasn shows the Kbhb site and the substrate binding pocket.